• Ki-67, Immunohistochemistry (IHC)
  • Heparin Induced Antibody
  • Hepatitis E Virus (HEV) RNA, Molecular, Quantitative
  • Carnitine-Acylcarnitine Translocase Deficiency, Gene Mutation Analysis
  • Quetiapine, Serum or Urine
  • Chromatin Antibody, IgG
  • Circulating Tumor Cells (CTC), Colon Cancer
  • Nordiazepam, Urine
  • Coccidioides By Molecular Method, Body Fluid
  • Anti-SARS-CoV-2 (Coronavirus), IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis
Medical Test

References
Access to Prolyl Hydroxylase Domain-2 (PHD2/EGLN1) Gene Mutation Analysis is restricted.
Loading...